10 Jun

HealthBeacon innovation featured as part of MedTechWeek

HealthBeacon featured as part of the MedTechWeek publication in the Irish Independent reflecting on our eHealth Innovation of the year award from the Irish Medtech Association. Hear from CTO Kieran Daly on how the award impacted HealthBeacon and the wider plans as the organisation continues to scale.

Click on the link below to see the article & read the interview.

Innovation in Medtech

09 May

HealthBeacon Labs shortlisted for design award

We are very excited to announce that the HealthBeacon User Experience Lab has been shortlisted for the UX 2019 Awards in the UX Achievement in Health and Lifestyle category.

We have achieved 90% patient acceptance rates with our current product, which we firmly believe is a testament to our patient-centric design ethos. To embed this across our organisation we created the User Experience Lab. An immersive experience where one can step into the shoes of a patient, empathise and understand their needs. This Lab will ensure we maintain this ethos as we design and release new products and will also help our clients truly understand the challenges that their patients are facing.

Karen Tracey

Product Designer

 

 

03 May

Malin Johansson to become Vice President of Europe for HealthBeacon

Malin Johansson to become Vice President of Europe for HealthBeacon

Dublin, Ireland Headquartered, HealthBeacon, a leading global medical adherence technology provider whose mission is to “build smart tools for managing medications” will be establishing a dedicated European division to drive further growth of its technology platform. It’s FDA cleared “best in class” medical adherence tool for tracking injectable medications has already been globally launched in 11 countries. This new division will be responsible for all European markets outside of the UK and Ireland and we are delighted to announce that Malin Johansson will be heading up this group. In her role as Vice President of Europe she will be responsible for developing both the market and the HealthBeacon organisation across this important region.

 

“We have known Malin for years from her impressive career in Pharmaceuticals working for Abbott/AbbVie in both Medical Device, Patient Experience and Marketing functions with Affiliate, Nordic, Europe and Global responsibilities and we couldn’t be more excited to work with her again. Malin is a passionate evangelist for implementing technology and solutions that make a real difference in patients’ lives and has extensive experience specifically implementing digital health solutions in Europe.”

Jim Joyce, CEO and Co-founder, HealthBeacon

 

“I am delighted to be joining this innovative, fast growing technology company with a clear mission to support people that requires to take mediciations home and Health Care systems around the world with trusted information around medication adherence and consumption. Today, HealthBeacon has implemented it’s technology in a number of European countries; Germany, Portugal, Ireland, Netherlands, Belgium, and Italy. My ambition would be to rapidly expand the implementation and increase the number of countries we support in Europe to allow a wider access to HealthBeacon´s technology. In doing so, HealthBeacon will strenghten their existing business relationships and become a strategic and strong partner to support the expansion of future connected medicines.”

Malin Johansson, VP of Europe, HealthBeacon

Malin most recently was Senior Global Marketing Manager,  Immunology Strategic Operations, Global Marketing at AbbVie responsible for developing and implementing the AbbVie Immunology leadership identity for their portfolio of assets  and for driving adoption of technology and marketing solutions across the world. She will work between Paris and Stockholm, while covering all of Europe. Outside of work Malin is an active mom and a passionate soccer fan with her club being the Swedish AIK where her two daughters play.

16 Apr

Future Pharma Leader Network 2019

Dave Shanahan sets up a Future Pharma Leader Network 2019 Dinner Series hosted at HealthBeacon Headquarters.

Who is Dave Shanahan, by Jim Joyce: When I think of Pharmaceutical Leadership in Ireland one name jumps to everyone’s short list, Dave Shanahan. Dave went from a Janssen medical  sales representative to becoming the Managing Director Manager of Pfizer Ireland during the days when category leading medication, Lipitor, was redefining the industry. He lead IDA’s global Life Sciences division, became a top executive for AbbVie out of Chicago, is the founding chair of the Irish government’s Health Innovation Hub and today sits on the board of Enterprise Ireland. HealthBeacon is lucky to have him heading Partnership Initiatives since our founding in 2013. Dave is a high energy, personable connector of ideas and people in healthcare and is certainly a leader.

What is the Future Pharma Leader Network 2019?  It’s a small network of people working in the Pharmaceutical industry who have been selected by their bosses as Future Pharma Leaders.

Dave, in your words tell us more? “One of the joys of looking back on a long pharma career is reflecting on some great people and presentations along the way which enabled new thinking and new friendships. Many Irish leaders are in the vanguard of the changes presently sweeping healthcare and pharma. Think of the convergence of pharma, medtech, digital tech and healthcare services, the rise of genomics and digital health, new economic realities impacting demographics and cost. Pharma’s business model is facing profound challenges and opportunities.

So, we’ve decided to host some evening events for an exclusive group of Pharma executives we’re calling the Future Pharma Leader Network. We’re bringing terrific speakers to address our network and engage with them on topics which are disrupting healthcare today”

Who is invited? We reached out to Ireland’s current Pharma Leaders in the commercial divisions of the major pharmaceutical companies and asked each of them to nominate people who they thought were Future Pharma Leaders. We received 34 nomination with contributions from almost every major pharmaceutical company that has a presence in Ireland. Unfortunately, we couldn’t accommodate everyone so our final list is 25 highly talented ambitious pharma executives.

Who is speaking at the inaugural event? One of Ireland’s great healthcare innovators the legendary Professor Brendan Buckley. His resume includes: Chief Medical Officer Tekro, Former Chief Medical Officer of ICON, Co-founder Firecrest, Consultant Endocrinologist, Chairperson Fighting Blindness, Clinical Professor University College of Cork, and a great speaker!

Can you tell us about future speakers? We have a great list in development, we want people with a unique perspective on the Pharma industry and a proven track record of success, who are willing to share their perspective with talented emerging pharma execs. Think exciting Biotech CEOs, Proven Health and Tech Innovators, Ministers, Pharma Execs with International Careers, Payors, Health System Leaders…

Why set this up? We believe these 25 nominees are capable of defining the pharmaceutical industry in Ireland and abroad. We wanted to give them a space to interact with each other over a meal, hear a great thought provoking speaker and critically discuss the opportunities and changes that will affect the Pharmaceutical industry.

Will you run this event outside of Ireland? That’s the plan, but let’s run this one first.

Is this event open to anyone? No, you must be nominated to attend the event and we are keeping it small to allow people a chance to interact with each other.

24 Oct

HealthBeacon attends Johnson & Johnson, JLABS CEO Summit

HealthBeacon are delighted to attend the 2nd annual JLABs CEO Summit in sunny La Jolla, San Diego. 

The event has gathered partners of Johnson & Johnson’s, JLABs group for two days of networking and information exchange as well as talks and panel discussions with industry leaders. 

HealthBeacon has been part of the global JLABs network after being chosen as the winner of the Johnson & Johnson Innovation, JLABS and Janssen Supply Chain Group, LLC (JSC) Patient Adherence QuickFire Challenge earlier this year.

Since winning the QuickFire Challenge, HealthBeacon has achieved FDA clearance for it’s smart sharps bin and launched in an additional four markets including the U.S. so there is a lot to catch up on with old friends and new at the event. 

This coupled with the growth of our product portfolio and data analytics platform offers a clear point of intersection within the JLABs ecosystem.

Having completed day one of the event which was focussed on JPAL & Investor Partnering we are excited to partake in the CEO Summit main program which began tonight featuring talks from J&J executives, JLABS CEOs, investors and industry leaders, and continues on Wednesday 24th.

 

22 Dec

HealthBeacon Smart Sharps System is approved by Israeli Ministry of Health and launched into the Israeli market

HealthBeacon were honoured to host Israeli Ambassador Zeev Boker, Deputy Ambassador Orli Weitzman and Commercial Representative Colin Sheena to our Dublin offices this week to mark the launch of HealthBeacon in Israel.

For Israeli patients that take injectable medications it is often a struggle to stay on their treatment schedule, now they can have access to our medical adherence tools and platform.

We are excited to launch in Israel with our first Patients going live this week. This is a key milestone in our development and along with our Partners we look forward to building on this success based on a shared approach to innovation in Patient support. Jim Joyce, CEO, HealthBeacon

Ambassador Zeev Boker & CTO Kieran Daly exchanging gifts.

 

09 Feb

HealthBeacon raises €1m in seed funding…

HealthBeacon raises €1m in seed funding to roll out medical adherence device internationally

HealthBeacon raises €1m in seed funding to roll out medical adherence device internationallyLondon, UK (February 9th, 2016)

Earlier today HealthBeacon, a digital health platform connecting devices and data for better health delivery, announced the completion of its €1m seed investment round to support the launch of its medical adherence device for patients on self injectable medications. The announcement came during an exclusive digital health care event at the Imperial College of London.

HealthBeacon, founded in 2014, by both Jim Joyce, serial healthcare entrepreneur, and Kieran Daly, former CEO of Shimmer, developed its first device – to help patients on self injectable medication adhere to their medical schedules.

Medical adherence, helping patients comply with treatment regimens is one of the largest problems facing healthcare systems. Evidence suggests that patients on average comply with their medicine schedules only 50-70% of the time. The pharmaceutical market for patients who self administer medicines by injections is estimated to be over €40b.

2016, will be a breakout year for the HealthBeacon platform, our first product for self injectable medications is being rolled out internationally to 1,000s of patients”, said Jim Joyce, co-founder HealthBeacon, at the digital health event in London.

Millions of patients worldwide treat devastating chronic diseases like Diabetes, Multiple Sclerosis, Arthritis, Gastro Conditions, and Heart Disease by self administering injections in their home. Unfortunately, many of these patients struggle to comply with their treatment.

The HealthBeacon team has designed a device that knows when a patient has taken their medication and critically if they have forgotten, or missed a dose. If they miss an injection, their HealthBeacon will send a simple reminder to their phone. The result is potentially a more compliant and healthier patient.

HealthBeacon is a significant advancement in the management of self injectable medications, we can now have confidence that a patient has taken their medication on time when in the home“, said Professor Douglas Veale, Consultant Rheumatologist, Adjunct Professor of Medicine, University College Dublin.

The company launched the device in Ireland in 2015 and has worked with Cleveland Clinic Innovation Centre to assess how the tool could be integrated into clinical care pathways globally.

HealthBeacon is putting a focus on the very important issue of improving medical adherence, while trying to improve overall patient/physican engagement and health delivery”, said Brian Kolonick, General Manager, Global Healthcare Innovation Alliance, Cleveland Clinic.

The funding from the seed round will be used to commercially roll out the tool across Europe. Investors in the seed round include the Irish government through Enterprise Ireland, and private medical and technology angel investors.

HealthBeacon’s digital platform exploits the increased trend in healthcare to connect devices and data for better health delivery. The internet of things (IoT) trend will drive fast adoption and scaling of the platform, especially as it supports lower cost health delivery in the community of patients who previously were only administered their treatment in hospital.

23 Apr

HealthXL, HealthBeacon, Cleveland Clinic Launch Research Collab…

HealthXL, HealthBeacon, and Cleveland Clinic Launch Research Collaboration to Revolutionize the Management of Self Injectable Medication at Home

Today HealthXL announced that two of its partners HealthBeacon and Cleveland Clinic are exploring opportunities to change the way patients manage self injectable medications in the home.

The HealthBeacon system helps patients manage self injectable medications in the home. The device is an elegant tool that engages patients who take self injectable medication and improves their compliance to therapy, while practically dealing with their medical waste. The HealthBeacon system is in the advanced prototype stage and is launching into European Markets in the second quarter of 2015. HealthBeacon’s objective with this 12 week project is to gain valuable clinical insights and initiate a working relationship with Cleveland Clinic and to help prepare the product for launch into the USA later in the year.

HealthBeacon was introduced to the HealthXL partners and advisors at the Cleveland Innovation Summit (October 2014). Their proposal aligned closely with the HealthXL Moonshots in the areas of Connected Health and Behaviour Change.

“We are thrilled to work with such a prestigious institution as Cleveland Clinic. This collaboration allows us to scale our operations globally very quickly and reach out to many more patients to help them manage their medications in the home. HealthXL has been the catalyser that invigorated the development of this exciting opportunity.” says Kieran Daly Co-Founder at HealthBeacon.

“New collaborations are needed to drive innovation in healthcare that can scale globally. And that’s our mission to catalyse collaboration between leading brands in healthcare and the most exciting tech companies to improve the lives of millions of people” said Martin Kelly, CEO and Co-Founder of HealthXL.

HealthXL and their group of partners are constantly exploring similar opportunities in healthcare to work with high growth companies, increasing the speed at which existing digital health technologies can begin to have a meaningful impact on health outcomes.

1 Definition of HealthXL Moonshot: an ambitious endeavor where it is clear WHAT the desired outcome in healthcare is, but not clear HOW it will be achieved. The HealthXL Moonshot on Connected Health is “To Be Able to Monitor the Health of Every Patient from Birth to Death: Anytime, in Any Location”, while the one on Behavior Change is “To Have Millions of Hearts Beating Younger, Stronger and Longer through Increased Patient Engagement.”

© 2015 Health Beacon - Privacy Policy - Website by Medusa